BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 22882359)

  • 1. Contribution of highly sensitive diagnostic methods to the diagnosis of systemic mastocytosis in the absence of skin lesions.
    Alvarez-Twose I; Matito A; Sánchez-Muñoz L; Morgado JM; Orfao A; Escribano L; van Doormaal JJ; van der Veer E; van Voorst Vader PC; Kluin PM; Mulder AB; van der Heide S; Arends S; Kluin-Nelemans JC; Oude Elberink JN; de Monchy JG
    Allergy; 2012 Sep; 67(9):1190-1. PubMed ID: 22882359
    [No Abstract]   [Full Text] [Related]  

  • 2. Tryptase and histamine metabolites as diagnostic indicators of indolent systemic mastocytosis without skin lesions.
    van Doormaal JJ; van der Veer E; van Voorst Vader PC; Kluin PM; Mulder AB; van der Heide S; Arends S; Kluin-Nelemans JC; Oude Elberink JN; de Monchy JG
    Allergy; 2012 May; 67(5):683-90. PubMed ID: 22435702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical markers predictive for bone marrow involvement in systemic mastocytosis.
    Donker ML; van Doormaal JJ; van Doormaal FF; Kluin PM; van der Veer E; de Monchy JG; Kema IP; Kluin-Nelemans HC
    Haematologica; 2008 Jan; 93(1):120-3. PubMed ID: 18166795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Systemic mastocytosis as a cause of osteoporosis].
    Kemink SA; Smals AG; Kloppenborg PW
    Ned Tijdschr Geneeskd; 1996 Jun; 140(24):1277-9. PubMed ID: 8700283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Vulvar oedema revealing systemic mastocytosis].
    Deveza E; Locatelli F; Girardin M; Valmary-Degano S; Daguindau E; Aubin F; Humbert P; Pelletier F
    Ann Dermatol Venereol; 2015 Nov; 142(11):685-9. PubMed ID: 26003033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved diagnosis of mastocytosis by measurement of urinary histamine metabolites.
    Keyzer JJ; de Monchy JG; van Doormaal JJ; van Voorst Vader PC
    N Engl J Med; 1983 Dec; 309(26):1603-5. PubMed ID: 6646186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diminished reliability of tryptase as risk indicator of mastocytosis in older overweight subjects.
    Vos BJ; van der Veer E; van Voorst Vader PC; Mulder AB; van der Heide S; Arends S; Kluin-Nelemans JC; de Monchy JG; van Doormaal JJ; Oude Elberink JN
    J Allergy Clin Immunol; 2015 Mar; 135(3):792-8. PubMed ID: 25129675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [An infant with macules and papules].
    van der Waa JD; Vredenborg AD
    Ned Tijdschr Geneeskd; 2020 Aug; 164():. PubMed ID: 32940988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Urticaria pigmentosa/systemic mastocytosis].
    Moretti D; Kilstein J; Zicre D; Bagilet DH
    Med Clin (Barc); 2011 Apr; 136(12):558. PubMed ID: 20149398
    [No Abstract]   [Full Text] [Related]  

  • 10. Increased risk of malignant melanoma in patients with systemic mastocytosis?
    Hägglund H; Sander B; Gülen T; Lindelöf B; Nilsson G
    Acta Derm Venereol; 2014 Sep; 94(5):583-4. PubMed ID: 24473924
    [No Abstract]   [Full Text] [Related]  

  • 11. Therapeutic challenge during the long-term follow-up of a patient with indolent systemic mastocytosis with extensive cutaneous involvement.
    Marton I; Pósfai É; Borbényi Z; Bödör C; Papp G; Demeter J; Korom I; Varga E; Bata-Csörgő Z
    Eur Rev Med Pharmacol Sci; 2015; 19(9):1607-9. PubMed ID: 26004600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mastocytosis with urticaria pigmentosa and osteoporosis.
    Stein JA; Kamino H; Walters RF; Pomeranz MK
    Dermatol Online J; 2008 Oct; 14(10):2. PubMed ID: 19061601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response of urticaria pigmentosa to cladribine in a patient with systemic mastocytosis.
    Bennett M; Chubar Y
    Br J Haematol; 2013 Feb; 160(4):420. PubMed ID: 23205635
    [No Abstract]   [Full Text] [Related]  

  • 14. Undiagnosed systemic mastocytosis in a teenager revealed during general anesthesia.
    Goldfinger MM; Sandadi J
    Paediatr Anaesth; 2010 Mar; 20(3):290-1. PubMed ID: 20470330
    [No Abstract]   [Full Text] [Related]  

  • 15. Indolent systemic mastocytosis: a case and review of the current available treatment options.
    Lee Y; Wood P; Soyer HP
    Dermatol Online J; 2013 Jun; 19(6):18562. PubMed ID: 24011312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mastocytosis. Main symptoms of cutaneous mastocytosis: urticaria pigmentosa].
    Kolyvanos Naumann U; Käser L; Vetter W
    Praxis (Bern 1994); 2005 Sep; 94(36):1373-9; quiz 1380. PubMed ID: 16190370
    [No Abstract]   [Full Text] [Related]  

  • 17. [Anaphylactoid reaction in occult systemic mastocytosis. A rare dermatologic emergency ].
    Ständer H; Beier K; Metze D; Brehler R
    Hautarzt; 2005 Mar; 56(3):265-9. PubMed ID: 15619082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mast Cell Burden in a Patient With Cutaneous Disease.
    Awosika O; Eleryan M; Rengifo-Pardo M; Ehrlich A
    J Drugs Dermatol; 2017 Dec; 16(12):1285-1287. PubMed ID: 29240865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased leukotriene E4 excretion in systemic mastocytosis.
    Butterfield JH
    Prostaglandins Other Lipid Mediat; 2010 Jun; 92(1-4):73-6. PubMed ID: 20380889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mastocytosis.
    Abid A; Malone MA; Curci K
    Prim Care; 2016 Sep; 43(3):505-18. PubMed ID: 27545739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.